Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-25 @ 2:44 AM
NCT ID:
NCT00842933
Eligibility Criteria:
Inclusion Criteria:
* Patients who are 18 years of age or older
* Patients who sign informed consent or are represented by a legally authorized representative to provide consent on behalf of the patient
* Patients with septic shock meeting the ACCM/SCCM consensus conference definitions for septic shock
Exclusion Criteria:
* Patients with documented allergic or anaphylactic reactions to corticosteroids
* Patients who have received steroid therapy within 6 months of presentation
* Patients who have received steroids during their hospital admission, with the exception of a single dose of dexamethasone
* Patients who have received etomidate in the preceding 12 hours
* Patients who have had a prior adrenalectomy or a known history of adrenal disease (documented adrenal insufficiency or Cushing syndrome).
* Documented Human Immunodeficiency Virus (HIV) infection
* Pregnancy
* Allergies to adrenocorticotropic hormone (ACTH) or corticosteroids
* Administration of additional medications which may suppress the hypothalamic-pituitary axis:
* Ketoconazole
* Aminoglutethimide
* Mitotane
* Megestrol acetate
* Suramin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00842933
Study Brief:
Protocol Section:
NCT00842933